Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2025 is -10.02% vs 4.02% in Mar 2025
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is -37.05% vs 74.74% in Mar 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2025 is -18.80% vs 14.49% in Mar 2025
Interest
QoQ Growth in quarter ended Jun 2025 is 2.33% vs -21.82% in Mar 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025
Compare Quarterly Results Of Dermapharm Holding SE With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is -10.02% vs 4.02% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -2.75% vs 6.39% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is -37.05% vs 74.74% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 24.40% vs 276.84% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is -18.80% vs 14.49% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 1.09% vs -5.60% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is 2.33% vs -21.82% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -14.84% vs 9.93% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025
YoY Growth in quarter ended Jun 2025 has improved from Jun 2024






